New Delhi [India], March 22 (ANI): As India's cumulative COVID-19 vaccination coverage exceeded 181.56 crore, Union Health Minister Mansukh Mandaviya on Tuesday said that the vaccination journey has been extraordinary and an epitome of the power of 'Sabka Prayas'.
Beijing [China], March 22 (ANI): China's efforts to establish itself as a responsible global actor by supplying COVID-19 vaccines to various countries amid the pandemic has faltered due to the inadequate efficacy of its vaccines in comparison to vaccines supplied by other global players incl
New Delhi [India], March 21 (ANI): As the country is rapidly pacing its speed to fully inoculate the eligible population with both the doses of COVID-19 vaccines, sources have now learned that the decision on administering booster or precaution dose for those above 18 years of age has not
Seoul [South Korea], March 21 (ANI/Global Economic): S. Korea has become a global production hub to supply generic drugs for Covid-19 treatments to middle- and low-income countries. From vaccines to oral treatments, Korea has been recognized for the production and supply of Covid-19 drugs
New Delhi [India], March 20 (ANI): The National Technical Advisory Group on Immunization (NTAGI) on Sunday recommended the Union Ministry of Health to reduce the COVID-19 vaccine Covishield's duration of the second dose to somewhere between 8 to 16 weeks after the first dose in view of the o
New Delhi [India], March 19 (ANI): India reported a total of 2,075 new COVID-19 cases in the last 24 hours, taking the total number of infections to 4,30,06,080, informed the Ministry of Health and Family Welfare on Saturday.
Ottawa [Canada], March 19 (ANI/Xinhua): Canada's chief public health officer on Friday called for more people to get a booster to make the public health system more resilient as the country began to lift COVID-19 restriction measures, such as limits on social gatherings and mask mandates.
Washington [US], March 18 (ANI/Xinhua): American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already recei
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
New Delhi [India], March 17 (ANI): As many as 3,907 doses of COVID-19 vaccines have been administered to beneficiaries aged between 12-14 years in the national capital till 7:30 PM on Thursday.
Brussels [Belgium], March 17 (ANI/Sputnik): The European Union is experiencing another surge in COVID-19 cases as member countries continue to lift restrictions and return to pre-pandemic life, Marco Cavaleri, the head of the Biological Health Threats and Vaccines Strategy of the European Me